When certain connections in the brain do not function correctly, disorders such as Parkinson’s disease, dystonia, obsessive-compulsive disorder (OCD), and Tourette’s syndrome may result. Targeted stimulation of specific areas in the brain can help…
Scientists still are not sure how neurological symptoms arise in COVID-19. Is it because SARS-CoV-2 infects the brain? Or are these symptoms the result of inflammation in the rest of the body? A study by Charité – Universitätsmedizin Berlin has now…
Deadline: April 26, 2024
MTIP invested $15 million to accelerate Caresyntax's commercial growth and to expand its data-driven surgery platform.
● The Fund’s focus is on healthcare innovations that improve patient outcomes
● Leveraging Earlybird Eagle Eye, a cutting-edge proprietary AI tool, the Fund
gains deal flow and market intelligence
● Uniquely, the only European fund with public…
FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications
Special receptor cells under the skin enable us to feel pain and touch. But Schwann cells also play a key role in detecting such stimuli, researchers at the Max Delbrück Center report in “Nature Communications.” This discovery opens new avenues for…
A new computer program allows scientists to design synthetic DNA segments that indicate, in real time, the state of cells. Reported by the Gargiulo lab in “Nature Communications”, it will be used to screen for anti-cancer or viral infections drugs,…
Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus Rajewsky from the Max…
Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have new findings on brain stiffness as a marker of neuroinflammation in multiple sclerosis to report. In this section, they answer questions about their research…
